Skip to Content

'
Kelly K. Hunt, M.D., F.A.C.S.

Present Title & Affiliation

Primary Appointment

Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Chief, Breast Surgical Oncology Section, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Hamill Foundation Distinguished Professorship in Honor of Dr. Richard G. Martin, Sr., Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Associate Professor, Division of Surgery, The University of Texas Health Science Center at Houston Medical School, Houston, TX
Professor, Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1986 The University of Tennessee Center for the Health Sciences, Memphis, TN, MD, with highest honors
1982 Memphis State University, Memphis, TN, BSC, summa cum laude, Chemistry

Postgraduate Training

7/1994-6/1996 Fellow in Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
7/1992-6/1993 Chief Resident in General Surgery, University of California Los Angeles School of Medicine, Los Angeles, CA
7/1991-12/1991 Registrar in General and Vascular Surgery, University Hospital, Queen's Medical Centre, Nottingham, United Kingdom
7/1990-6/1991 Assistant Resident in General Surgery, Department of Surgery, University of California Los Angeles School of Medicine, Los Angeles, CA
7/1988-6/1990 NIH Surgical Oncology & American Cancer Society Research Fellowship, Division of Surgical Oncology, University of California Los Angeles School of Medicine, Los Angeles, CA
7/1986-6/1988 Resident, Surgery, Department of Surgery, University of California Los Angeles School of Medicine, Los Angeles, CA

Board Certifications

10/2001 Diplomate of the American Board of Surgery
1987 Diplomate of the National Board of Medical Examiners

Selected Publications

Peer-Reviewed Original Research Articles

1. Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Ann Surg Oncol 19(12):3777-3784, 11/2012. PMID: 22622473.
2. Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 133(3):1131-41, 6/2012. e-Pub 3/4/2012. PMID: 22392043.
3. Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, goiffon RJ, Goldstein TC, NG S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Letich M, Hunt KK, Olson J, Tao Y, Maher CA, fulton LL, fulton RS, Harris M, Oberkfell B, Du F, Demeter R, vickery TL, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling DJ, Ota D, Chang L-W, bose R, Ley TJ, Piwnica-Worms D, Stuart JM, Wilson RK, Mardis ER. Whole-genome analysis informs breast cancer esponse to aromatase inhibition. Nature 486(7403):353-360, 6/2012.
4. Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam F. Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer. e-Pub 5/30/2012. PMID: 22648744.
5. Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian I. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res 14(3). e-Pub 5/23/2012. PMID: 22621306.
6. Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo AM, Hoffman K, Meric-Bernstam F, Hunt KK, Buchholz TA, Mittendorf EA. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res 14(3). e-Pub 5/23/2012. PMID: 22621334.
7. Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JN. Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery 151(5):710-6, 5/2012. e-Pub 1/29/2012. PMID: 22285778.
8. Kim MM, Dawood S, Allen P, Sahin AA, Woodward WA, Smith BD, Strom EA, Hunt KK, Meric-Bernstam F, Gonzalez-Angulo AM, Buchholz TA. Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer. Cancer. e-Pub 4/17/2012. PMID: 22511276.
9. Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT. Imaging features of primary breast sarcoma. AJR Am J Roentgenol 198(4):W386-93, 4/2012. PMID: 22451578.
10. Wagner JL, Fearmonti R, Hunt KK, Hwang RF, Meric-Bernstam F, Kuerer HM, Bedrosian I, Crosby MA, Baumann DP, Ross MI, Feig BW, Krishnamurthy S, Hernandez M, Babiera GV. Prospective Evaluation of the Nipple-Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer. Ann Surg Oncol 19(4):1137-44, 4/2012. e-Pub 10/7/2011. PMID: 21979111.
11. Nanos-Webb A, Jabbour NA, Multani AS, Wingate H, Oumata N, Galons H, Joseph B, Meijer L, Hunt KK, Keyomarsi K. Targeting low molecular weight cyclin E (LMW-E) in breast cancer. Breast Cancer Res Treat 132(2):575-88, 4/2012. e-Pub 6/22/2011. PMID: 21695458.
12. Wu Y, Mittendorf EA, Kelten C, Tucker SL, Wei W, Middleton LP, Broglio K, Buchholz TA, Hunt KK, Sahin AA. Occult axillary lymph node metastasis do not have prognostic significance in early stage breast cancer. Cancer 118(6):1507-14, 3/15/2012. e-Pub 8/25/2011. PMID: 22009292.
13. Kelly CM, Green MC, Broglio K, Thomas ES, Brewster AM, Valero V, Ibrahim NK, Gonzalez-Angulo AM, Booser DJ, Walters RS, Hunt KK, Hortobagyi GN, Buzdar AU. Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer. J Clin Oncol 30(9):930-5, 3/20/2012. e-Pub 2/13/2012. PMID: 22331946.
14. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy. Ann Surg Oncol 19(3):901-7, 3/2012. e-Pub 8/23/2011. PMID: 21861223.
15. Duong MT, Akli S, Wei C, Wingate HF, Liu W, Lu Y, Yi M, Mills GB, Hunt KK, Keyomarsi K. LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients. PLoS Genet 8(3):e1002538, 3/2012. e-Pub 3/29/2012. PMCID: PMC3315462.
16. Chawla A, Hunt KK, Mittendorf EA. Surgical considerations in patients receiving neoadjuvant systemic therapy. Future Oncol 8(3):239-250, 3/2012. PMID: 22409461.
17. Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, Garza JG, Shen J, Lin K, Yan P, Glynn SA, Dorsey TH, Hunt KK, Ambs S, Johanning GL. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst 104(3):189-210, 2/8/2012. e-Pub 1/12/2012. PMCID: PMC3274512.
18. Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 30(6):600-7, 2/2012. e-Pub 1/2012. PMCID: PMC3295558.
19. Yi M, Liu P, Li X, Mittendorf EA, He J, Ren Y, Nayeemuddin K, Hunt KK. Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States. Cancer. e-Pub 1/3/2012. PMID: 22460701.
20. Bilimoria KY, Wayne JD, Merkow RP, Abbott DE, Cormier JN, Feig BW, Hunt KK, Pisters PW, Pollock R, Bentrem DJ. Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States. Ann Surg Oncol 19(1):184-91, 1/2012. e-Pub 7/2/2011. PMID: 21725688.
21. Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255(1):109-15, 1/2012. PMID: 22167004.
22. Lester TR, Hunt KK, Nayeemuddin KM, Bassett RL, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis WG, Valero V, Gilcrease MZ. Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers. Breast Cancer Res Treat 131(1):41-8, 1/2012. e-Pub 2/18/2011. PMID: 21331622.
23. Yi M, Mittendorf EA, Cormier JN, Buchholz TA, Bilimoria K, Sahin AA, Hortobagyi GN, Gonzalez-Angulo AM, Luo S, Buzdar AU, Crow JR, Kuerer HM, Hunt KK. Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current American Joint Committee on Cancer Staging System. J Clin Oncol 29(35):4654-61, 12/10/2011. e-Pub 11/14/2011. PMCID: PMC3236648.
24. Nagar H, Mittendorf EA, Strom EA, Perkins GH, Oh JL, Tereffe W, Woodward WA, Gonzalez-Angulo AM, Hunt KK, Buchholz TA, Yu TK. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer. Int J Radiat Oncol Biol Phys 81(3):782-7, 11/1/2011. e-Pub 8/30/2011. PMID: 21885207.
25. Haffty BG, Hunt KK, Harris JR, Buchholz TA. Positive Sentinel Nodes Without Axillary Dissection: Implications for the Radiation Oncologist. J Clin Oncol. e-Pub 10/31/2011. PMID: 22042942.
26. Roses RE, Arun BK, Lari SA, Mittendorf EA, Lucci A, Hunt KK, Kuerer HM. Ductal Carcinoma-In-Situ of the Breast with Subsequent Distant Metastasis and Death. Ann Surg Oncol 18(10):2873-8, 10/2011. e-Pub 4/8/2011. PMID: 21476105.
27. Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, Wagner J, Hunt KK, Woodward WA, Meric-Bernstam F. Triple-negative breast cancer is not a contraindication for breast conservation. Ann Surg Oncol 18(11):3164-73, 10/2011. e-Pub 9/27/2011. PMID: 21947595.
28. Durak MG, Gonzalez-Angulo AM, Hanrahan EO, Broglio KR, Valero V, Hortobagyi GN, Hunt KK, Sahin AA. Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer. Breast J 17(5):462-9, Sep-Oct, 9/2011. e-Pub 7/5/2011. PMID: 21726347.
29. Buchholz TA, Hunt KK. Breast conservation therapy in the 21st century. Breast J 17(5):445-7, Sep-Oct, 9/2011. PMID: 21899648.
30. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA. Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing Trial. Ann Surg Oncol 18(9):2407-12, 9/2011. e-Pub 2/15/2011. PMID: 21327455.
31. Van Leeuwen BL, Rosenkranz KM, Feng LL, Bedrosian I, Hartmann K, Hunt KK, Kuerer HM, Ross M, Singletary SE, Babiera GV, Department of Surgical Oncology, MD Anderson Cancer Center. The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol 79(3):315-20, 9/2011. e-Pub 7/23/2010. PMID: 20655242.
32. Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton L, Sahin A, Xing Y, Hunt KK, Chen J, Bu H, Rashid A, Abraham SC, Wu Y. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol 42(8):1169-77, 8/2011. e-Pub 2/21/2011. PMID: 21334720.
33. Wray CJ, Benjamin RS, Hunt KK, Cormier JN, Ross MI, Feig BW. Isolated limb perfusion for unresectable extremity sarcoma: Results of 2 single-institution phase 2 trials. Cancer 117(14):3235-41, 7/15/2011. e-Pub 1/18/2011. PMID: 21246524.
34. Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, Morrow M, Leitch AM, Hunt KK, McCall LM, Abati A, Cote R. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 306(4):385-393, 7/2011.
35. Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam F. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg 254(1):119-24, 7/2011. PMID: 21494124.
36. Valero V, Wingate H, Chada S, Liu Y, Palalon F, Mills G, Keyomarsi K, Hunt KK. MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells. Cancer Gene Ther 18(7):510-9, 7/2011. e-Pub 5/6/2011. PMID: 21546925.
37. Albert JM, Buzdar AU, Guzman R, Allen PK, Strom EA, Perkins GH, Woodward WA, Hoffman KE, Tereffe W, Hunt KK, Buchholz TA, Oh JL. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Treat 128(2):421-7, 7/2011. e-Pub 5/8/2011. PMID: 21553292.
38. Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, Deschryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA. Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype--ACOSOG Z1031. J Clin Oncol 29(17):2342-9, 6/10/2011. e-Pub 5/9/2011. PMCID: PMC3107749.
39. Kronowitz SJ, Lam C, Terefe W, Hunt KK, Kuerer HM, Valero V, Lance S, Robb GL, Feng L, Buchholz TA. A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up. Plast Reconstr Surg 127(6):2154-66, 6/2011. PMID: 21311392.
40. Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, Martin M, Cotrina J, Gomez H, Hubbard R, Chacón JI, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O'Shaughnessy J, Hortobagyi GN, Symmans WF. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305(18):1873-81, 5/11/2011. PMID: 21558518.
41. Hsu C, Vega F, Grimes LM, Hunt KK. Follicular dendritic cell sarcoma and associated myasthenia gravis: true, true, related? J Clin Oncol 29(13):e369-71, 5/1/2011. e-Pub 2/14/2011. PMID: 21321294.
42. Mittendorf EA, Jeruss JS, Tucker SL, Kolli A, Newman LA, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol 29(15):1956-62, 5/20/2011. e-Pub 4/11/2011. PMCID: PMC3107758.
43. Bloom ES, Kirsner S, Mason BE, Nelson CL, Hunt KK, Baumann DP, Gifford KA. Accelerated partical breast irradiation using the strut-adjusted volume implant single-entry hybrid catheter in brachytherapy for breast cancer in the setting of breast augmentation. Brachytherapy 10(3):178-83, May-Jun, 5/2011. e-Pub 8/17/2010. PMID: 20719576.
44. Sharma R, Rourke LL, Kronowitz SJ, Oh JL, Lucci A, Litton JK, Robb GL, Babiera GV, Mittendorf EA, Hunt KK, Kuerer HM. Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy. Plast Reconstr Surg 127(5):1763-72, 5/2011. PMID: 21532405.
45. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer. Ann Surg Oncol 18(4):932-8, 4/2011. e-Pub 11/9/2010. PMID: 21061075.
46. Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, Ross MI, Babiera GV, Kuerer HM, Hunt KK. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer 117(5):916-24, 3/1/2011. e-Pub 10/13/2010. PMID: 20945319.
47. Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, Kuerer HM, Luo S, Gonzalez-Angulo AM, Buzdar AU, Symmans WF, Feig BW, Lucci A, Huang EH, Hunt KK. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg 253(3):572-9, 3/2011. PMID: 21209588.
48. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569-75, 2/9/2011. PMID: 21304082.
49. Caudle AS, Hunt KK. The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore. Curr Opin Obstet Gynecol 23(1):31-6, 2/2011. PMID: 21124221.
50. Kuerer HM, Buzdar AU, Mittendorf EA, Esteva FJ, Lucci A, Vence LM, Radvanyi L, Meric-Bernstam F, Hunt KK, Symmans WF. Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast. Cancer 117(1):39-47, 1/1/2011. e-Pub 8/24/2010. PMCID: PMC2997136.
51. Ylipää A, Hunt KK, Yang J, Lazar AJ, Torres KE, Lev DC, Nykter M, Pollock RE, Trent J, Zhang W. Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors. Cancer 117(2):380-9, 1/15/2011. e-Pub 9/3/2010. PMCID: PMC3008331.
52. Valero V, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EA. Sentinel lymph node dissection is technically feasible in older breast cancer patients. Clin Breast Cancer 10(6):477-82, 12/1/2010. PMID: 21147692.
53. Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Hunt KK, Lucci A. Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Ann Surg Oncol 17(12):3252-8, 12/2010. e-Pub 6/18/2010. PMID: 20559739.
54. Shinde SS, Forman MR, Kuerer HM, Yan K, Peintinger F, Hunt KK, Hortobagyi GN, Pusztai L, Symmans WF. Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer. Cancer 116(21):4933-43, 11/1/2010. PMID: 20665494.
55. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TA. Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer. Cancer. e-Pub 11/8/2010. PMID: 21061345.
56. Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang Y, Cogdell D, Price ND, Pollock RE, Lazar AJ, Hunt KK, Trent JC, Zhang W. Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug. Mol Cell Proteomics 9(11):2405-13, 11/2010. e-Pub 7/22/2010. PMCID: PMC2984227.
57. Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HM. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol 17(11):2899-908, 11/2010. e-Pub 5/5/2010. PMID: 20443145.
58. Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, Bedrosian I, Hwang RF, Lucci A, Meric-Bernstam F. Does blue dye contribute to success of sentinel node mapping for breast cancer? Ann Surg Oncol 17(Suppl 3):280-5, 10/2010. e-Pub 9/19/2010. PMID: 20853047.
59. Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KK. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol 17(Suppl 3):343-51, 10/2010. e-Pub 9/19/2010. PMID: 20853057.
60. Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer 116(17):4000-6, 9/1/2010. PMID: 20564117.
61. Caruso JA, Hunt KK, Keyomarsi K. The neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer. Cancer Res 70(18):7125-36, 9/15/2010. e-Pub 9/7/2010. PMCID: PMC2940941.
62. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252(3):426-32; discussion 432-3, 9/2010. PMID: 20739842.
63. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, Woodward WA, Tucker SL, Hunt KK, Hortobagyi GN, Buchholz TA. Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys 77(5):1296-302, 8/1/2010. e-Pub 5/14/2010. PMID: 20472353.
64. Wilke LG, Ballman KV, McCall LM, Giuliano AE, Whitworth PW, Blumencranz PW, reintgen DS, Burak WE, Leitch AM, Hunt KK. Adherence to the National Quality Forum (NQF) Breast Cancer Measures Within Cancer Clinical Trials: A Review From ACOSOG Z0010. Ann Surg Oncol 17(8):1989-94, 8/2010. PMID: 20309640.
65. Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam F. Factors Affecting the Decision of Breast Cancer Patients to Undergo Contralateral Prophylactic Mastectomy. Cancer Prev Res (Phila) 3(8):1026-34, 8/2010. e-Pub 7/20/2010. PMID: 20647335.
66. Mittendorf EA, Liu Y, Tucker SL, McKenzie T, Qiao N, Akli S, Biernacka A, Liu Y, Meijer L, Keyomarsi K, Hunt KK. A novel interaction between HER2/neu and cyclin E in breast cancer. Oncogene 29(27):1-12, 7/8/2010. e-Pub 5/10/2010. PMCID: PMC2900397.
67. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 116(11):2543-8, 6/1/2010. PMID: 20336790.
68. Brown AS, Hunt KK, Shen J, Huo L, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Boughey JC, Ching CD, Gilcrease MZ. Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer 116(12):2878-83, 6/15/2010. PMID: 20564394.
69. Bagheri-Yarmand R, Biernacka A, Hunt KK, Keyomarsi K. Low Molecular Weight cyclin E Overexpression Shortens Mitosis, Leading to Chromosome Missegregation and Centrosome Amplification. Cancer Res 70(12):5074-84, 6/15/2010. e-Pub 6/8/2010. PMCID: PMC2888821.
70. Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou C, Smith KD, Phung TL, Pollock RE, Benjamin R, Hunt KK, Lazar AJ, Lev D. Angiosarcoma: clinical and molecular insights. Ann Surg 251(6):1098-106, 6/2010. PMID: 20485141.
71. Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Le-Petross HT, Babiera GV, Meric-Bernstam F, Hunt KK, Kuerer HM. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 116(12):2884-9, 6/2010. PMID: 20564395.
72. Wei B, Ding T, Xing Y, Wei W, Tian Z, Tang F, Abraham S, Nayeemuddin K, Hunt K, Wu Y. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer, 6/2010. PMID: 20572042.
73. Rourke LL, Hunt KK, Cormier JN. Breast cancer and lymphedema: a current overview for the healthcare provider. Womens Health (Lond Engl) 6(3):399-406, 5/2010. PMID: 20426606.
74. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Liu P, Pusztai L, Symmans WF, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol 28(11):1821-8, 4/10/2010. e-Pub 3/15/2010. PMCID: PMC2860366.
75. Yang D, Ylipaa A, Yang J, Hunt K, Pollock R, Trent J, Yli-Harja O, Shmulevich I, Nykter M, Zhang W. An integrated study of aberrant gene copy number and gene expression in GIST and LMS. Technol Cancer Res Treat 9(2):171-8, 4/2010. PMID: 20218739.
76. Nguyen CV, Falcón-Escobedo R, Hunt KK, Nayeemuddin KM, Lester TR, Harrell RK, Bassett RL, Gilcrease MZ. Pleomorphic Ductal Carcinoma of the Breast: Predictors of Decreased Overall Survival. Am J Surg Pathol 34(4):486-93, 4/2010. e-Pub 2/11/2010. PMID: 20154588.
77. Sun B, Wingate H, Swisher SG, Keyomarsi K, Hunt KK. Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells. Cell Cycle 9(6):1-9, 3/15/2010. e-Pub 3/15/2010. PMID: 20237430.
78. Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi K. Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors. Clin Cancer Res 16(4):1179-90, 2/15/2010. e-Pub 2/9/2010. PMCID: PMC2822889.
79. Silberfein EJ, Hunt KK, Broglio K, Shen J, Sahin A, Le-Petross H, Oh J, Litton J, Hwang RF, Mittendorf EA. Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma. Clin Breast Cancer 10(1):52-8, 2/2010. PMID: 20133259.
80. Anaya DA, Lahat G, Wang X, Xiao L, Pisters PW, Cormier JN, Hunt KK, Feig BW, Lev DC, Pollock RE. Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol 21(2):397-402, 2/2010. e-Pub 7/2009. PMID: 19622598.
81. Fearmonti RM, Keyomarsi K, Hunt KK. Biomarkers in Neoadjuvant Trials. Hormone Receptors in Breast Cancer. 147, 1/2010.
82. Fearmonti RM, Gayed IW, Kim E, Bedrosian I, Hunt KK, Meric-Bernstam F, Feig B, Ghonimi E, Warneke C, Babiera GV. Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer. Ann Surg Oncol 17(1):220-7, 1/2010. e-Pub 8/13/2009. PMID: 19680729.
83. Mittendorf EA, Wu Y, Scaltriti M, Meric-Bernstam F, Hunt KK, Dawood S, Esteva FJ, Buzdar AU, Chen H, Eksambi S, Hortobagyi GN, Baselga J, Gonzalez-Angulo AM. Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes. Clin Cancer Res 15(23):7381-8, 12/1/2009. e-Pub 11/17/2009. PMCID: PMC2788123.
84. Sparano JA, Pisano ED, White JR, Hunt KK, Mamounas EP, Perez EA, Hortobagyi GN, Gralow JR, Comis RL. Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy. Breast Cancer Res Treat. e-Pub 12/19/2009. PMID: 20024613.
85. Fearmonti RM, Batista LI, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Eva Singletary S, Babiera GV. False Negative Rate of Sentinel Lymph Node Biopsy in Multicentric and Multifocal Breast Cancers May be Higher in Cases with Large Additive Tumor Burden. Breast J 15(6):645-8, Nov-Dec, 11/2009. e-Pub 9/7/2009. PMID: 19735388.
86. Boughey JC, Goravanchi F, Parris RN, Kee SS, Kowalski AM, Frenzel JC, Bedrosian I, Meric-Bernstam F, Hunt KK, Ames FC, Kuerer HM, Lucci A. Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg 198(5):720-725, 11/2009. e-Pub 5/9/2009. PMID: 19427625.
87. Smith GL, Xu Y, Shi T-C T, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast-Conserving Surgery in Older Patients with Invasicve Breast Cancer: Current Patterns of Treatment Across the United States. J Am Coll Surg 209(4):425-433, 10/2009.
88. Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera G, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, and Meric-Bernstam F. Sentinel Lymph Node Surgery after Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer Patients Annals of Surgery. Annals of Surg 250(4), 10/2009.
89. Lahat G, Dhuka AR, Lahat S, Lazar AJ, Lewis VO, Lin PP, Feig B, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Lev D. Complete Soft Tissue Sarcoma Resection is a Viable Treatment Option for Select Elderly Patients. Ann Surg Oncol 16(9):2579-2586, 9/2009. e-Pub 6/26/2009. PMID: 19557478.
90. Boughey JC, Goravanchi F, Parris RN, Kee SS, Frenzel JC, Hunt KK, Ames FC, Kuerer HM, Lucci A. Improved Postoperative Pain Control using Thoracic Paravertebral Block for Breast Operations. Breast J 15(5):483-8, Sep-Oct, 9/2009. e-Pub 7/13/2009. PMID: 19624418.
91. Wagner J, Boughey JC, Garrett B, Babiera G, Kuerer H, Meric-Bernstam F, Singletary E, Hunt KK, Middleton LP, Bedrosian I. Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer. Am J Surg 198(3):387-391, 9/2009. e-Pub 4/10/2009. PMID: 19362281.
92. Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, Ravi V, Lazar AJ, Lev D. Outcome of Locally Recurrent and Metastatic Angiosarcoma. Ann Surg Oncol 16(9):2502-2509, 9/2009. e-Pub 6/24/2009. PMID: 19551444.
93. Blazer DG, Lazar AJ, Xing Y, Askew RL, Feig BW, Pisters PW, Pollock RE, Lev D, Hunt KK, Cormier JN. Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. Cancer 115(13):2971-9, 7/1/2009. PMID: 19402173.
94. Wagner M, Roh V, Strehlen M, Laemmle A, Stroka D, Egger B, Trochsler M, Hunt KK, Candinas D, Vorburger SA. Effective Treatment of Advanced Colorectal Cancer by Rapamycin and 5-FU/Oxaliplatin Monitored by TIMP-1. J Gastrointest Surg. e-Pub 6/2009.
95. Boughey JC, Wagner J, Garrett BJ, Harker L, Middleton LP, Babiera GV, Meric-Bernstam F, Lucci A, Hunt KK, Bedrosian I. Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation. Ann Surg Oncol 16(6):1606-1611, 6/2009. e-Pub 3/12/2009. PMID: 19280264.
96. Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AM. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med 6(5):e1000068, 5/26/2009. e-Pub 5/5/2009. PMCID: PMC2673042.
97. Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 115(7):1555-62, 4/1/2009. e-Pub 2/2009. PMID: 19195040.
98. Delk NA, Hunt KK, Keyomarsi K. Altered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation. Cancer Res 69(7):2817-2825, 4/1/2009. e-Pub 3/24/2009. PMCID: PMC2669888.
99. Lahat G, Lazar A, Wang X, Wang WL, Zhu QS, Hunt KK, Pollock RE, Lev D. Increased Vascular Endothelial Growth Factor-C Expression Is Insufficient to Induce Lymphatic metastasis in Human Soft-Tissue Sarcomas. Clin Cancer Res 15(8):2637-2646, 4/15/2009. e-Pub 4/7/2009. PMID: 19351758.
100. McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC. A randomized, Phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis. Ann Surg Oncol 16(4):910-919, 4/2009. e-Pub 10/25/2008. PMID: 18953611.
101. Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K and Keyomarsi K. Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Cell Cycle 8(7):1062-1068, 4/2009.
102. Downs-Kelly E, Nayeemuddin KM, Albarracin C, Wu Y, Hunt KK, Gilcrease MZ. Matrix-producing Carcinoma of the Breast: An Aggressive Subtype of Metaplastic Carcinoma. Am J Surg Pathol 33(4):534-41, 4/2009. e-Pub 11/26/2008. PMID: 19047898.
103. Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer 115(5):962-971, 3/1/2009. PMID: 19172584.
104. Yang J, Du X, Chen K, Ylipää A, Lazar AJ, Trent J, Lev D, Pollock R, Hao X, Hunt K, Zhang W. Genetic aberrations in soft tissue leiomyosarcoma. Cancer Lett 275(1):1-8, 3/2009. PMID: 18649996.
105. Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M. Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience. Oncology 77(2):75-81, 2009. e-Pub 7/1/2009. PMCID: PMC2790774.
106. Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15(12):3369-77, 12/2008. e-Pub 9/25/2008. PMID: 18815841.
107. Lambert LA, Qiao N, Hunt KK, Lambert DH, Mills GB, Meijer L, Keyomarsi K. Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68(19):7966-74, 10/1/2008. PMCID: PMC2561224.
108. Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 72(2):474-84, 10/1/2008. e-Pub 4/24/2008. PMID: 18439768.
109. Roh V, Laemmle A, Von Holzen U, Stroka D, Dufour JF, Hunt KK, Candinas D, Vorburger SA. Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer Gene Ther 15(10):636-44, 10/2008. e-Pub 6/6/2008. PMID: 18535617.
110. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, Bassett RL, Hunt KK. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol 191(3):646-52, 9/2008. PMID: 18716089.
111. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Staging of breast cancer in the neoadjuvant setting. Cancer Res 68(16):6477-81, 8/15/2008. PMID: 18701468.
112. Pataer A, Hu W, Xiaolin L, Chada S, Roth JA, Hunt KK, Swisher SG. Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing. Mol Cancer Ther 7(8):2528-35, 8/2008. PMCID: PMC2597048.
113. Yang J, Du X, Lazar AJ, Pollock R, Hunt K, Chen K, Hao X, Trent J, Zhang W. Genetic aberrations of gastrointestinal stromal tumors. Cancer 113(7):1532-1543, 7/31/2008. PMID: 18671247.
114. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, Piyathilake CJ, Hunt KK, Johanning GL. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res 68(14):5869-77, 7/15/2008. PMID: 18632641.
115. Olson JA, McCall LM, Beitsch P, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, American College of Surgeons Oncology Group Trials Z0010 and Z0011. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 26(21):3530-5, 7/20/2008. PMID: 18640934.
116. Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 7/15/2008. e-Pub 1/30/2008. PMID: 18234447.
117. Chen LL, Holden JA, Choi H, Zhu J, Wu EF, Jones KA, Ward JH, Andtbacka RH, Randall RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, Benjamin RS, Frazier ML. Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 21(7):826-36, 7/2008. e-Pub 5/16/2008. PMID: 18488000.
118. Lu J, Wei Q, Bondy ML, Brewster AM, Bevers TB, Yu TK, Buchholz TA, Meric-Bernstam F, Hunt KK, Singletary SE, Wang LE. Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged </=55 years. Breast Cancer Res Treat 110(2):357-66, 7/2008. e-Pub 9/13/2007. PMID: 17851762.
119. Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KK. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196(1):81-7, 7/2008. e-Pub 4/23/2008. PMID: 18436181.
120. Jeruss JS, Newman LA, Ayers GD, Cristofanilli M, Broglio KR, Meric-Bernstam F, Yi M, Waljee JF, Ross MI, Hunt KK. Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer 112(12):2646-54, 6/15/2008. PMID: 18442039.
121. Rao R, Feng L, Kuerer HM, Singletary SE, Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC, Babiera GV. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 15(6):1696-702, 6/2008. e-Pub 3/21/2008. PMID: 18357493.
122. Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482-8, 5/20/2008. e-Pub 4/21/2008. PMID: 18427152.
123. Al-Refaie WB, Andtbacka RH, Ensor J, Pisters PW, Ellis TL, Shrout A, Hunt KK, Cormier JN, Pollock RE, Feig BW. Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas. Cancer 112(8):1821-6, 4/15/2008. PMID: 18306370.
124. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol 26(2):246-52, 1/10/2008. e-Pub 12/3/2007. PMID: 18056680.
125. Pataer A, Chada S, Roth JA, Hunt KK, Swisher SG. Development of Ad-mda7/IL-24-resistant lung cancer cell lines. Cancer Biol Ther 7(1):103-8, 1/2008. e-Pub 10/13/2007. PMID: 18059175.
126. Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi K, Bedrosian I. Cyclin E deregulation is an early event in the development of breast cancer. Breast Cancer Res Treat, 2008. e-Pub 12/2008.
127. Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, Ross MI, Kuerer HM, Singletary SE, Bedrosian I. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 110(11):2542-50, 12/1/2007. PMID: 17932905.
128. Yokota T, Bui T, Liu Y, Yi M, Hunt KK, Keyomarsi K. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta. Cancer Res 67(23):11272-83, 12/1/2007. PMID: 18056453.
129. Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GH, Buchholz TA. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420-7, 12/1/2007. PMID: 17941034.
130. Yang WT, Hennessy B, Broglio K, Mills C, Sneige N, Davis WG, Valero V, Hunt KK, Gilcrease MZ. Imaging differences in metaplastic and invasive ductal carcinomas of the breast. AJR Am J Roentgenol 189(6):1288-93, 12/2007. PMID: 18029860.
131. Kronowitz SJ, Hunt KK, Kuerer HM, Strom EA, Buchholz TA, Ensor JE, Koutz CA, Robb GL. Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy. Plast Reconstr Surg 120(7):1755-68, 12/2007. PMID: 18090737.
132. von Holzen U, Pataer A, Raju U, Bocangel D, Vorburger SA, Liu Y, Lu X, Roth JA, Aggarwal BB, Barber GN, Keyomarsi K, Hunt KK, Swisher SG. The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation. Clin Cancer Res 13(20):6032-9, 10/15/2007. PMID: 17947465.
133. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-31, 10/2007. PMID: 17826073.
134. Pisters PW, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, Wei C, Ballo MT. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246(4):675-81; discussion 681-2, 10/2007. PMID: 17893504.
135. Boughey JC, Middleton LP, Harker L, Garrett B, Fornage B, Hunt KK, Babiera GV, Dempsey P, Bedrosian I. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg 194(4):450-5, 10/2007. PMID: 17826054.
136. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110(4):723-30, 8/15/2007. PMID: 17587208.
137. Williams SA, Ehlers RA, Hunt KK, Yi M, Kuerer HM, Singletary SE, Ross MI, Feig BW, Symmans WF, Meric-Bernstam F. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer 110(4):731-7, 8/15/2007. PMID: 17582626.
138. Hayes-Jordan A, Anderson P, Curley S, Herzog C, Lally KP, Green HL, Hunt K, Mansfield P. Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor. J Pediatr Surg 42(8):E29-32, 8/2007. PMID: 17706484.
139. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25(24):3657-63, 8/2007. PMID: 17485711.
140. McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SW, Yu TK, Strom EA, Oh JL, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68(4):1004-9, 7/15/2007. PMID: 17418973.
141. Sher T, Hennessy BT, Valero V, Broglio K, Woodward WA, Trent J, Hunt KK, Hortobagyi GN, Gonzalez-Angulo AM. Primary angiosarcomas of the breast. Cancer 110(1):173-8, 7/1/2007. PMID: 17541936.
142. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109(7):1255-63, 4/1/2007. PMID: 17330229.
143. Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 14(4):1458-71, 4/2007. PMID: 17260108.
144. Yang WT, Hennessy BT, Dryden MJ, Valero V, Hunt KK, Krishnamurthy S. Mammary angiosarcomas: imaging findings in 24 patients. Radiology 242(3):725-34, 3/2007. PMID: 17325063.
145. Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I, Zhang W. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A 104(9):3414-9, 2/27/2007. PMID: 17360660.
146. Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TA. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys 67(2):490-6, 2/1/2007. PMID: 17236970.
147. Buzdar AU, Valero V, Ibrahim NK, Francis D, Broglio KR, Theriault RL, Pusztai L, Green MC, Singletary SE, Hunt KK, Sahin AA, Esteva F, Symmans WF, Ewer MS, Buchholz TA, Hortobagyi GN. Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen. Clin Cancer Res 13(1):228-33, 1/1/2007. PMID: 17200359.
148. Pataer A, Bocangel D, Chada S, Roth JA, Hunt KK, Swisher SG. Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue. Cancer Gene Ther 14(1):12-8, 1/2007. PMID: 17024233.
149. Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 67(1):158-63, 1/2007. PMID: 17084545.
150. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Treng J, patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 14(1):14-24, 1/2007.
151. Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, Huan S, Huang M, Liu J, Sahin AA, Hunt KK, Bast RC, Shen Y, Issa JP, Yu Y. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res 9(4):R57, 2007. PMID: 17764565.
152. Huang EH, Strom EA, Perkins GH, Oh JL, Chen AM, Meric-Bernstam F, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys, 8/2006. PMID: 16887286.
153. Pataer A, Fanale MA, Roth JA, Swisher SG, Hunt KK. Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Cancer Gene Ther 13(8):806-14, 8/2006. PMID: 16628227.
154. Boughey JC, Ross MI, Babiera GV, Bedrosian I, Feig BW, Hwang RF, Kuerer HM, Hunt KK. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer 7(3):248-53, 8/2006. PMID: 16942642.
155. Peintinger F, Symmans WF, Gonzalez-Angulo AM, Boughey JC, Buzdar AU, Yu TK, Hunt KK, Singletary SE, Babiera GV, Lucci A, Meric-Bernstam F, Kuerer HM. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 107(6):1248-1254, 7/2006. PMID: 16862596.
156. Kawase K, Gayed IW, Hunt KK, Kuerer HM, Akins J, Yi M, Grimes L, Babiera GV, Ross MI, Feig BW, Ames FC, Singletary SE, Buchholz TA, Symmans WF, Meric-Bernstam F. Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg 203(1):64-72, 7/2006. PMID: 16798488.
157. Bocangel D, Zheng M, Mhashilkar A, Liu Y, Ramesh R, Hunt KK, Chada S. Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells. Cancer Gene Ther, 6/2006. PMID: 16783343.
158. Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13(6):776-82, 6/2006. PMID: 16614878.
159. Mansfield PF, Hunt KK. Classification, staging, and management of Non-Hodgkin's lymphomas. Surgical Oncology:203-11, 1/1997.
160. Swisher SG, Schmit PJ, Hunt KK, Hiyama DT, Bennion RS, Swisher EM, Thompson JE. Biliary disease during pregnancy. Am J Surg 168(6):576-9; discussion 580-1, 12/1994. PMID: 7977999.
161. Swisher SG, Hunt KK, Schmit PJ, Hiyama DT, Bennion RS, Thompson JE. Management of pancreatitis complicating pregnancy. Am Surg 60(10):759-62, 10/1994. PMID: 7944038.
162. Miller AR, McBride WH, Hunt K, Economou JS. Cytokine-mediated gene therapy for cancer. Ann Surg Oncol 1(5):436-50, 9/1994.
163. Swisher SG, Cates JA, Hunt KK, Robert ME, Bennion RS, Thompson JE, Roslyn JJ, Reber HA. Pancreatitis associated with adult choledochal cysts. Pancreas 9(5):633-7, 9/1994. PMID: 7809018.
164. Alvarez C, Hunt K, Ashley SW, Reber HA. Emphysematous cholecystitis after ERCP. Dig Dis Sci 39(8):17, 19-23, 8/1994.
165. Hunt KK, Shibata M, Gupta RK, Morton DL. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen. Cancer Immunol Immunother 34(6):377-82, 1992. PMID: 1563014.

Invited Articles

1. Hunt KK, Woodward WA. Have we made progress in inflammatory breast cancer? Not so fast. Oncology (Williston Park) 25(3):276, 278, 3/2011. PMID: 21548471.
2. Litton JK, Hunt KK. Management of the contralateral breast in women with newly diagnosed breast cancer CME. Medscape, 4/2009.
3. Modi S, Hunt KK, Hudis CA. Preoperative chemotherapy for breast cancer: pearls and pitfalls. Medscape, 3/2009.

Book Chapters

1. Hunt KK, Green MC, Buchholz TA. Diseases of the Breast. In: Sabiston Textbook of Surgery, 19th. Ed(s) CM Townsend, RD Beauchamp, BM Evers and KL Mattox. Elsevier: Canada, 824-869, 2012. ISBN: 978-1-4377-1560-6.
2. Hunt KK, Litton JK. Systemic Treatment Strategies For Early Stage Breast Cancers. In: Surgery: Evidence-Based Medicine. People's Medical Publishing House - USA: Shelton CT, 604-611, 2012. ISBN: 13978607951094.
3. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Breast Cancer - Axillary Management. In: Year Book of Oncology 2011, 2011. Elsevier, 29-30, 2011.
4. Buchholz TA, Hunt KK. Breast-Conserving Therapy: Conventional Whole Breast Irradiation. In: Diseases of the Breast, 4th. Ed(s) Harris JR, Lippman ME, Morrow M, Osborne CK. Lippincott Williams & Wilkins: Philadelphia, PA, 507-528, 2010.
5. Torres, KE, Pollock RE and Hunt KK. Forequarter Amputation. In: Master Techniques in Breast Surgery, 2010.
6. Hunt KK and Boughey JC. The ACOSOG Experience. In: Kuerer’s Breast Surgical Oncology. Ed(s) Kuerer H, 517-530, 2010.
7. Ching CD, Hunt KK. Percutaneous Ablation: Minimally Invasive Techniques in Breast Cancer Therapy. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. 1, 4th. Ed(s) Bland KI, Copeland EM. Saunders (Elsevier), 1043-1050, 2009.
8. Fearmonti RM, Beahm EK, Pollock RE, Hunt KK. Surgical Procedures for Advanced Local and Regional Malignancies of the Breast. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. 1, 4th. Ed(s) Bland KI, Copeland EM. Saunders (Elsevier), 1147-1173, 2009.
9. Hunt KK, Newman LA, Copeland EM, Bland KI. The Breast. In: Schwartz’s Principles of Surgery, 9th. Ed(s) Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock RE. McGraw-Hill, 2009.
10. Hunt KK. Kelly K. Hunt. In: Legends and Legacies: Personal Journeys of Women Physicians and Scientists at M. D. Anderson Cancer Center, 1st, 52-60, 2008.
11. Strom EA, Buzdar AU, Hunt KK. Multidisciplinary care of breast cancer patients: Overview and implementation. In: M. D. Anderson Cancer Care Series: Breast Cancer, 2nd ed. Ed(s) Hunt KK, Robb GL, Strom EA, Ueno N. Springer: New York, NY, 197-234, 2008.
12. Boughey JC, Beahm EK, Hunt KK. Oncoplastic surgery for breast cancer. In: Textbook of Surgical Oncology. Ed(s) Poston GJ, Beauchamp D, Ruers T. Informa Healthcare: London & New York, 2008. ISBN: 9781841845074.
13. McKenzie-Johnson T, Sahin A, Hunt KK. Sentinel lymph node dissection: Indications, technique and results. In: Advanced Therapy in Surgical Oncology. Ed(s) Pollock RE, Ross MI, Curley SA, Perrier ND. BC Decker Inc: Hamilton, Ontario, 511-22, 2008.
14. Hunt KK. American College of Surgeons Oncology Group (ACOSOG). In: BIG – An overview of recent & ongoing clinical trials for breast cancer, 4th ed. Cambridge University Press: UK, 2007.
15. Chada S, Bocangel D, Pataer A, Mhashilkar AM, Inoue S, Miyahara R, Roth JA, Grimm EA, Swisher SG, Hunt KK, Ramesh R. MDA-7/IL-24 as a multi-modality therapy for cancer. In: Gene Therapy for Cancer. Ed(s) Hunt KK, Vorburger SA, Swisher, SG. Humana Press: Totowa, NJ, 413-34, 2007.
16. Andtbacka RHI, Meric-Bernstam F, Robinson EK, Hunt KK. Noninvasive breast cancer. In: The M. D. Anderson Surgical Oncology Handbook, 4th ed. Ed(s) Feig BW, Berger DH, Fuhrman GM. Lippincott Williams and Wilkins: Philadelphia, PA, 1-22, 2006.
17. Browne TS, Chagpar A, Hunt KK, Ramirez P. Perioperative care for breast and gynecological neoplasms. In: Acute Care of the Cancer Patient. Ed(s) Shaw AD, Riedel BJ, Burton AW, Fields AI, Feeley TW (eds),. Taylor & Francis Group: Florida, 433-53, 2005.
18. Bedrosian I, Bland K, Hunt KK. Follow-up care of the breast cancer patient. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. Saunders (Elsevier) and W.B. Saunders Company, 1513-32, 2004.
19. Beahm EK, Pollock R, Hunt KK. Surgical procedures for advanced local and regional malignancies of the breast. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. Saunders (Elsevier) and W.B. Saunders Company, 1235-54, 2004.
20. Meric F, Robinson E, Hunt KK. Noninvasive breast cancer. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott Williams and Wilkins, 1-13, 2003.
21. Vorburger SA, Hunt KK. Experimental Approaches. In: Soft Tissue Sarcoma. BC Decker Inc, 375-90, 2002.
22. Bilimoria MM, Hunt KK. Stromal tumors of the stomach and small bowel. In: The Practice of General Surgery. W. B. Saunders Company, 405-8, 2002.
23. Hunt KK, Vorburger S, Cormier JN. Surgical approaches to extremity sarcoma. In: Soft Tissue Sarcoma. BC Decker Inc, 89-109, 2002.
24. Strom EA, Buzdar AU, Hunt KK. Multidisciplinary care of the breast cancer patient: Overview and implementation. In: M.D. Anderson Cancer Care Series, Breast Cancer. Springer, 1-19, 2001.
25. Meric F, Hunt KK. Surgical options for breast cancer. In: M.D. Anderson Cancer Care Series, Breast Cancer. Springer, 187-222, 2001.
26. Hunt KK, Buzdar AU. Breast conservation after tumor downstaging with induction chemotherapy. In: Breast Cancer: The M.D. Anderson Solid Tumor Oncology Series. Springer-Verlag, 196-207, 1999.
27. Robinson E, Hunt KK. Noninvasive breast cancer. In: The M. D. Anderson Surgical Oncology Handbook. Lippincott Williams and Wilkins, 1-2, 1999.
28. Hunt KK, Ross MI. Paget's disease of the nipple-areolar complex. In: Breast Cancer: The M.D. Anderson Solid Tumor Oncology Series. Springer-Verlag, 262-72, 1999.
29. Ross MI, Hunt KK. Role for lymphatic mapping and sentinel node biopsy in management of early-stage breast cancer. In: Singletary SE (ed), Breast Cancer: The M.D. Anderson Solid Tumor Oncology Series. Ed(s) Singletary SE. Springer-Verlag: New York, 171-83, 1999.
30. Hunt KK, Patel SR, Pollack A. Soft tissue sarcomas. In: Integrated Cancer Management: Surgery, Medical Oncology and Radiation Therapy. Marcel Dekker, Inc, 394-415, 1999.
31. Hunt KK, Singletary SE, Smith TL, Ross MI, Strom EA, McNeese MD, Ames FC. Conservation surgery and radiation: The M. D. Anderson Cancer Center experience. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. W.B. Saunders Company, 1179-82, 1998.
32. Hunt KK, Bland KI, Ellis LM. General considerations for follow-up. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. W.B. Saunders Company, 1460-74, 1998.
33. Hunt KK, Kroll SS, Pollock RE. Surgical procedures for advanced local and regional malignancies of the breast. In: The Breast: Comprehensive Management of Benign and Malignant Diseases,. W.B. Saunders Company, 1234-43, 1998.
34. Hunt KK, Ross MI. Changing trends in the diagnosis and treatment of early breast cancer. In: Surgical Oncology. Kluwer Academic Publishers: Norwell, MA, 171-201, 1997.
35. Love SM, Hunt KK. Diagnostic approaches to breast masses. In: Mastery of Surgery. Little Brown and Company, 563-9, 1997.
36. Hunt KK, Love S. Breast Disorders. In: McGraw-Hill Encyclopedia of Science and Technology. McGraw-Hill, Inc, 1996.
37. Morton DL, Hunt KK, Bauer RL, Lee JD. Immunotherapy by active immunization of the host using nonspecific agents: Clinical applications using intralesional therapy. In: Biologic Therapy of Cancer: Principles and Practice. J.B. Lippincott Company, 627-42, 1991.

Last updated: 8/28/2013